Gastrointestinal symptoms, including nausea, vomiting, and diarrhea, are more commonly observed with GLP-1RAs, particularly during dose escalation [28, 29]
The current evidence does not support a beneficial effect of these drug classes on muscle function, and their hypoglycaemic effects in people without diabetes mean that they are unlikely to be practical to test further
Additionally, addressing claim 2, all GLP-1 RAs tend to have somewhere around 25% lean mass loss , so we could reasonably assume that around 9.5% of the 12.5% retatrutide figure is non-lean mass (mostly adipose tissue), with the remaining 3% being lean mass (mostly muscle)
Rasinger JD, Lundebye A, Penglase S, Ellingsen S, Amlund H (2017) Methylmercury induced neurotoxicity and the influence of selenium in the brains of adult zebrafish ( Danio rerio )
That persistent presence means your appetite stays suppressed between meals, between snacks, and between those late-night trips to the kitchen that used to derail your progress